Press Resease

Fertility Services Market by Procedure (Assisted Reproductive Technology (ART), In-Vitro Fertilization, Artificial Insemination, Surrogacy, and Others); by Service (Donor and Non-donor); and by End-User (Fertility Clinics, Hospitals, and Clinical Research Institutes): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2024

Published Date: 04-Oct-2018 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3396 Status : Published

Global fertility services market expected to generate revenue of around USD 34,240 million by end of 2024, growing at a CAGR of around 9.2% between 2018 and 2024. Fertility services involve various procedures, which are used to treat infertility problems and genetic issues in order to help out in conception.

Description

The report covers forecast and analysis for the fertility services market on a global and regional level. The study provides historic data for 2016 and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the fertility services market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the fertility services market on a global level.

In order to give the users of this report a comprehensive view of the fertility services market, we have included the competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein procedure, services, and end-users segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Fertility Services Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research& development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

The study provides a decisive view of the fertility services market by segmenting the market based on procedure, services, end-users, and by geography. Based on the procedure, the market is segmented into assisted reproductive technology (ART), in-vitro fertilization, artificial insemination, surrogacy, and others. The in-vitro fertilization segment is further sub-segmented as intracytoplasmic sperm injection (ICSI) and pre-implantation genetic diagnostics (PGD). The artificial insemination segment is again further segmented into intrauterine insemination, intracervical insemination, and others. On the basis of services, the market is segmented into donor and non-donor. The donor segment is further sub-segmented into fresh donor and frozen donor. The non-donor segment is classified into fresh non-donor and frozen non-donor. The end-user segment is fragmented into fertility clinics, hospitals, and clinical research institutes. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further division into major countries including the U.S., Rest of North America, U.K., Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa and Rest of the Middle East and Africa. This segmentation includes demand for fertility services market based on individual procedure, services, end-users in all the regions and countries.

The report also includes detailed profiles of end players such as CooperSurgical, Inc., Vitrolife, Cook, Care Fertility, Monash IVF, INVO Bioscience, Carolinas Fertility Institute, Fertility Focus Ltd., Apollo Hospitals Enterprise Ltd., Merck, LABOTECT GmbH, and Olympus Corporation.

This report segments the global fertility services market as follows:

Global Fertility Services Market: Procedure Segment Analysis

  • Assisted Reproductive Technology (ART)
  • In-Vitro Fertilization
    • Intracytoplasmic Sperm Injection (ICSI) 
    • Pre-implantation Genetic Diagnostics (PGD)
  • Artificial Insemination
    • Intrauterine Insemination, 
    • Intracervical Insemination
    • Others
  • Surrogacy
  • Others 

Global Fertility Services Market: Services Segment Analysis

  • Donor
    • Fresh 
    • Frozen 
  • Non-donor
    • Fresh 
    • Frozen 

Global Fertility Services Market: End-users Segment Analysis

  • Fertility Clinics
  • Hospitals
  • Clinical Research Institutes

Global Fertility Services Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Fertility Services market, 2017 - 2024(USD Million)
    • 2.2. Global Fertility Services market: snapshot
  •  
  • Chapter 3. Fertility Services Market- Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global Fertility Services market drivers: impact analysis
      • 3.2.2. Decline in Fertility Rates
      • 3.2.3. Delayed Pregnancies in Women
      • 3.2.4. Technological Advancements with Respect to Fertility Treatment
      • 3.2.5. Growing Public Awareness about Infertility and the Available Treatment Options
    • 3.3. Market Restraints
      • 3.3.1. Global Fertility Services market restraints: impact analysis
      • 3.3.2. Multiple pregnancies
      • 3.3.3. High treatment costs of ARTs in developed countries
      • 3.3.4. Inadequate reimbursement policies
      • 3.3.5. Restrictive regulations and ethical concerns
    • 3.4. Opportunities
      • 3.4.1. Rising research & development activity for Fertility Services products
      • 3.4.2. Rise in fertility tourism
      • 3.4.3. Growing number of fertility clinics
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by procedure segment
      • 3.6.2. Market attractiveness analysis, by services segment
      • 3.6.3. Market attractiveness analysis, by end-users segment
      • 3.6.4. Market attractiveness analysis, by regional segment
  •  
  • Chapter 4. Global Fertility Services Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Fertility Services market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  •  
  • Chapter 5. Global Fertility Services Market- Procedure Segment Analysis
    • 5.1. Global Fertility Services market: product overview
      • 5.1.1. Global Fertility Services market revenue share, by procedures, 2017 and 2024
    • 5.2. Assisted Reproductive Technology (ART)
    • 5.3. In-Vitro Fertilization
      • 5.3.1. Global Fertility Services market for In-Vitro Fertilization, 2017 - 2024(USD Million)
      • 5.3.2. Intracytoplasmic Sperm Injection (ICSI), Fertility Services market for Instruments, 2017 - 2024(USD Million)
      • 5.3.3. Pre-implantation Genetic Diagnostics (PGD), Fertility Services market for Instruments, 2017 - 2024(USD Million)
    • 5.4. Artificial Insemination
      • 5.4.1. Global Fertility Services market for Artificial Insemination, 2017 - 2024 (USD Million)
      • 5.4.2. Intrauterine Insemination, Fertility Services market for Reagent & Media, 2017 - 2024 (USD Million)
      • 5.4.3. Intracervical Insemination, Fertility Services market for Reagent & Media, 2017 - 2024 (USD Million)
      • 5.4.4. Others, Fertility Services market for Reagent & Media, 2017 - 2024 (USD Million)
    • 5.5. Surrogacy
    • 5.6. Others
  •  
  • Chapter 6. Global Fertility Services Market- Services Segment Analysis
    • 6.1. Global Fertility Services market: form type overview
      • 6.1.1. Global Fertility Services market revenue share, by services, 2017 and 2024
    • 6.2. Donor
      • 6.2.1. Global Fertility Services market for Donor, 2017 - 2024 (USD Million)
      • 6.2.2. Global Fertility Services market for Fresh Donor, 2017 - 2024 (USD Million)
      • 6.2.3. Global Fertility Services market for Frozen Donor, 2017 - 2024 (USD Million)
    • 6.3. Non-donor
      • 6.3.1. Global Fertility Services market for Non-donor, 2017 - 2024 (USD Million)
      • 6.3.2. Global Fertility Services market for Fresh Non-donor, 2017 - 2024 (USD Million)
      • 6.3.3. Global Fertility Services market for Frozen Non-donor, 2017 - 2024 (USD Million)
  •  
  • Chapter 7. Global Fertility Services Market- End-users Segment Analysis
    • 7.1. Global Fertility Services market: form type overview
      • 7.1.1. Global Fertility Services market revenue share, by End-users, 2017 and 2024
    • 7.2. Fertility Clinics
      • 7.2.1. Global Fertility Services market for Fertility Clinics, 2017 - 2024 (USD Million)
    • 7.3. Hospitals
      • 7.3.1. Global Fertility Services market for Hospitals, 2017 - 2024 (USD Million)
    • 7.4. Clinical Research Institutes
      • 7.4.1. Global Fertility Services market for Clinical Research Institutes, 2017 - 2024 (USD Million)
  •  
  • Chapter 8. Global Fertility Services Market- Regional Segment Analysis
    • 8.1. Global Fertility Services market: regional overview
      • 8.1.1. Global Fertility Services market revenue share, by region, 2017 and 2024
    • 8.2. North America
      • 8.2.1. North America Fertility Services market revenue, by procedures, 2017 - 2024(USD Million)
      • 8.2.2. North America Fertility Services market revenue, by services, 2017 - 2024(USD Million)
      • 8.2.3. North America Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
      • 8.2.4. U.S.
        • 8.2.4.1. U.S. Fertility Services market revenue, by procedures, 2017 - 2024(USD Million)
        • 8.2.4.2. U.S. Fertility Services market revenue, by services, 2017 - 2024(USD Million)
        • 8.2.4.3. U.S. Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
      • 8.2.5. Rest of North America
        • 8.2.5.1. Rest of North America Fertility Services market revenue, by procedures, 2017 - 2024(USD Million)
        • 8.2.5.2. Rest of North America Fertility Services market revenue, by services, 2017 - 2024(USD Million)
        • 8.2.5.3. Rest of North America Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Fertility Services market revenue, by procedures, 2017 - 2024(USD Million)
      • 8.3.2. Europe Fertility Services market revenue, by services, 2017 - 2024(USD Million)
      • 8.3.3. Europe Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
      • 8.3.4. U.K.
        • 8.3.4.1. U.K. Fertility Services market revenue, by procedures, 2017 - 2024 (USD Million)
        • 8.3.4.2. U.K. Fertility Services market revenue, by services, 2017 - 2024 (USD Million)
        • 8.3.4.3. U.K. Fertility Services market revenue, by end-users, 2017 - 2024 (USD Million)
      • 8.3.5. Germany
        • 8.3.5.1. Germany Fertility Services market revenue, by procedures, 2017 - 2024(USD Million)
        • 8.3.5.2. Germany Fertility Services market revenue, by services, 2017 - 2024(USD Million)
        • 8.3.5.3. Germany Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Fertility Services market revenue, by procedures, 2017 - 2024(USD Million)
        • 8.3.6.2. France Fertility Services market revenue, by services, 2017 - 2024(USD Million)
        • 8.3.6.3. France Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
      • 8.3.7. Italy
        • 8.3.7.1. Italy Fertility Services market revenue, by procedures, 2017 - 2024(USD Million)
        • 8.3.7.2. Italy Fertility Services market revenue, by services, 2017 - 2024(USD Million)
        • 8.3.7.3. Italy Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
      • 8.3.8. Spain
        • 8.3.8.1. Spain Fertility Services market revenue, by procedures, 2017 - 2024(USD Million)
        • 8.3.8.2. Spain Fertility Services market revenue, by services, 2017 - 2024(USD Million)
        • 8.3.8.3. Spain Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
      • 8.3.9. Rest of Europe
        • 8.3.9.1. Rest of Europe Fertility Services market revenue, by procedures, 2017 - 2024(USD Million)
        • 8.3.9.2. Rest of Europe Fertility Services market revenue, by services, 2017 - 2024(USD Million)
        • 8.3.9.3. Rest of Europe Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Fertility Services market revenue, by procedures, 2017 - 2024 (USD Million)
      • 8.4.2. Asia Pacific Fertility Services market revenue, by services, 2017 - 2024(USD Million)
      • 8.4.3. Asia Pacific Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
      • 8.4.4. China
        • 8.4.4.1. China Fertility Services market revenue, by procedures, 2017 - 2024(USD Million)
        • 8.4.4.2. China Fertility Services market revenue, by services, 2017 - 2024(USD Million)
        • 8.4.4.3. China Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Fertility Services market revenue, by procedures, 2017 - 2024(USD Million)
        • 8.4.5.2. Japan Fertility Services market revenue, by services, 2017 - 2024(USD Million)
        • 8.4.5.3. Japan Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
      • 8.4.6. India
        • 8.4.6.1. India Fertility Services market revenue, by procedures, 2017 - 2024(USD Million)
        • 8.4.6.2. India Fertility Services market revenue, by services, 2017 - 2024(USD Million)
        • 8.4.6.3. India Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
      • 8.4.7. Southeast Asia
        • 8.4.7.1. Southeast Asia Fertility Services market revenue, by procedures, 2017 - 2024(USD Million)
        • 8.4.7.2. Southeast Asia Fertility Services market revenue, by services, 2017 - 2024(USD Million)
        • 8.4.7.3. Southeast Asia Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Fertility Services market revenue, by procedures, 2017 - 2024(USD Million)
        • 8.4.8.2. Rest of Asia Pacific Fertility Services market revenue, by services, 2017 - 2024(USD Million)
        • 8.4.8.3. Rest of Asia Pacific Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Fertility Services market revenue, by procedures, 2017 - 2024(USD Million)
      • 8.5.2. Latin America Fertility Services market revenue, by services, 2017 - 2024(USD Million)
      • 8.5.3. Latin America Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Fertility Services market revenue, by procedures, 2017 - 2024(USD Million)
        • 8.5.4.2. Brazil Fertility Services market revenue, by services, 2017 - 2024(USD Million)
        • 8.5.4.3. Brazil Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America Fertility Services market revenue, by procedures, 2017 - 2024(USD Million)
        • 8.5.5.2. Rest of Latin America Fertility Services market revenue, by services, 2017 - 2024(USD Million)
        • 8.5.5.3. Rest of Latin America Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
    • 8.6. Middle East and Africa
      • 8.6.1. Middle East and Africa Fertility Services market revenue, by procedures, 2017 - 2024(USD Million)
      • 8.6.2. Middle East and Africa Fertility Services market revenue, by services, 2017 - 2024(USD Million)
      • 8.6.3. Middle East and Africa Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
      • 8.6.4. GCC Countries
        • 8.6.4.1. GCC Countries Fertility Services market revenue, by procedures, 2017 - 2024(USD Million)
        • 8.6.4.2. GCC Countries Fertility Services market revenue, by services, 2017 - 2024(USD Million)
        • 8.6.4.3. GCC Countries Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
      • 8.6.5. Rest of Middle East and Africa
        • 8.6.5.1. Rest of Middle East and Africa Fertility Services market revenue, by procedures, 2017 - 2024(USD Million)
        • 8.6.5.2. Rest of Middle East and Africa Fertility Services market revenue, by services, 2017 - 2024(USD Million)
        • 8.6.5.3. Rest of Middle East and Africa Fertility Services market revenue, by end-users, 2017 - 2024(USD Million)
  •  
  • Chapter 9. Company Profile
    • 9.1. CooperSurgical, Inc.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Vitrolife
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Care Fertility
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Monash IVF
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. INVO Bioscience
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Carolinas Fertility Institute
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Fertility Focus Ltd.
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Apollo Hospitals Enterprise Ltd.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Merck
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. LABOTECT GMBH
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments
    • 9.11. Olympus Corporation
      • 9.11.1. Overview
      • 9.11.2. Financials
      • 9.11.3. Product portfolio
      • 9.11.4. Business strategy
      • 9.11.5. Recent developments

Methodology

Free Analysis

The services provided regarding fertilization to the infertile population are known as fertility services. In these services, the healthcare professionals assist for reproduction through various techniques, such as IVF, ART, surrogacy, and a few others. Increasing infertility ratio is one of the major factors triggering the growth of the fertility services market. Moreover, growing public awareness about infertility and the available treatment options will also boost the market significantly during the forecast period. The decreasing fertility rate in males and females can be due to numerous reasons, such as increasing cases of prostate cancer is one of the leading cause of infertility in males as it requires removal of the prostate gland which leads to infertility.  

The global fertility services market is segmented as a procedure, services, end-users, and by geography. Based on the procedure, the market is segmented into assisted reproductive technology (ART), in-vitro fertilization, artificial insemination, surrogacy, and others. The in-vitro fertilization segment is further sub-segmented into intracytoplasmic sperm injection (ICSI) and pre-implantation genetic diagnostics (PGD). The artificial insemination segment is again further segmented into intrauterine insemination, intracervical insemination, and others. On the basis of services, the market is segmented into donor and non-donor. The donor segment is further sub-segmented into fresh donor and frozen donor. The non-donor segment is classified into fresh non-donor and frozen non-donor. The end-user segment is bifurcated into fertility clinics, hospitals, and clinical research institutes.

Global Fertility Services Market

North America held a dominant share of the global market for fertility services in 2017 and is anticipated to continue its dominance in the forthcoming years as well. Advanced healthcare facility, available treatment options, and increasing rate of infertility will drive the market during the forecast period. Followed by North America, Europe is estimated to hold the second largest share in the global fertility services market. Asia Pacific region is expected to grow at the highest CAGR during the forecast period owing to the increasing awareness about infertility, changing lifestyle, and increasing disposable income will fuel the market growth in the region. Moreover escalating research and development expenditure, rising prevalence of PCOS and PCOD, and the decreasing fertility rate is some other factors expected to propel the growth of the fertility services market in the Asia Pacific. 

Some of the key players in the fertility services market are CooperSurgical, Inc., Vitrolife, Cook, Care Fertility, Monash IVF, INVO Bioscience, Carolinas Fertility Institute, Fertility Focus Ltd., Apollo Hospitals Enterprise Ltd., Merck, LABOTECT GmbH, and Olympus Corporation. Currently, the market’s growth rate is very high, which has encouraged the leading players to focus on consolidation through product licensing and long-term partnerships in order to gain maximum share in the market.

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com